| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Mar 6, 2025 | Innoviva, Inc. | 10% Owner | Sell | 15.0 | -1,618,295 | -22.24% | ✗ | $28.4M |
| Jun 15, 2023 | Jun 20, 2023 | Innoviva, Inc. | 10% Owner | Buy | 75.0 | +62,000 | 0.86% | ✗ | $814.2K |
| Jun 5, 2023 | Jun 7, 2023 | Innoviva, Inc. | 10% Owner | Buy | 65.0 | +15,000 | 0.21% | ✗ | $195.7K |
| May 25, 2023 | May 30, 2023 | Innoviva, Inc. | 10% Owner | Buy | 92.5 | +200,000 | 2.86% | ✗ | $2.6M |
| May 17, 2023 | May 19, 2023 | Innoviva, Inc. | 10% Owner | Buy | 87.5 | +96,000 | 1.39% | ✗ | $1.3M |
| May 17, 2023 | May 19, 2023 | Innoviva, Inc. | 10% Owner | Buy | 75.0 | +60,000 | 0.87% | ✗ | $784.2K |
| May 11, 2023 | May 15, 2023 | Innoviva, Inc. | 10% Owner | Buy | 92.5 | +290,000 | 4.38% | ✗ | $3.6M |
| Mar 8, 2021 | Mar 10, 2021 | IRONWOOD PHARMACEUTICALS INC | Director | Buy | 77.5 | +225,000 | 0.69% | ✗ | $2.3M |
| Mar 3, 2021 | Mar 5, 2021 | IRONWOOD PHARMACEUTICALS INC | Director | Buy | 88.8 | +775,000 | 2.49% | ✗ | $7.8M |
| Feb 11, 2021 | Feb 12, 2021 | Iterum Therapeutics plc | 10% Owner | Sell | 15.0 | -20,619,949 | -100.00% | ✗ | $50M |